Agalactosis: Understanding the Failure of Lactation Agalactosis is a medical condition characterized by the complete failure of the mammary glands to secrete milk following childbirth. While often discussed in veterinary contexts—particularly regarding livestock like sows and sheep—it also occurs in humans, where it presents significant physiological and psychological challenges for the mother and nutritional risks for the infant. Physiological Origins
It is crucial to distinguish true agalactosis from (insufficient milk supply). Most breastfeeding difficulties are related to "latch" issues, infrequent feeding, or delayed lactogenesis II (where milk "comes in" later than the typical 72-hour window). Agalactosis is absolute; regardless of stimulation or demand, the mammary glands remain inactive. Impact and Management agalactosis
In a biological sense, agalactosis historically represented a fatal threat to the newborn. In modern medicine, the physical threat is mitigated by high-quality infant formulas. However, the psychological impact on the mother can be profound. Many women experience a sense of "biological failure" or grief, necessitating empathetic clinical support and a focus on alternative bonding methods. In modern medicine, the physical threat is mitigated
Agalactosis remains a rare but definitive reminder of the complexity of the reproductive system. Whether caused by acute trauma, such as pituitary damage, or underlying systemic illness, it requires a multifaceted response that prioritizes infant nutrition while addressing the underlying hormonal or physical health of the mother. Because the pituitary produces prolactin
In humans, one of the most noted causes is , where severe postpartum hemorrhage leads to necrosis of the pituitary gland. Because the pituitary produces prolactin, its damage can permanently inhibit milk production. Other causes include severe primary mammary glandular hypoplasia (insufficient breast tissue) or rare genetic mutations affecting hormone receptors. Diagnostic Distinctions